Cardiology Activities
Clinical Updates for Specialty Pharmacists on PCSK9 Inhibitor Therapy
0290-0000-18-147-H01-P
This program presented by PTCE, with expert faculty, will enable participants to differentiate between the approved PCSK9 inhibitor therapies.
1.50
The Cardiovascular Benefits of Antihyperglycemic Medications
0290-0000-18-115-L01-P
This webinar will highlight efficacy and safety data of antihyperglycemic therapy options so that an appropriate therapy can be selected to minimize CVD in patients with T2DM.
8-22-2018
1.00
Specialty Pharmacy Updates on PCSK9 Inhibitor Therapy for Hypercholesterolemia
0290-0000-17-192-H01-P
The webinar will explore the economic burden of cardiovascular complications caused by high cholesterol, criteria for a benefit from PCSK9 inhibitors, and more.
1.00
An American Journal of Managed Care Symposium: Deliberations on New and Emerging Treatments for Hyperkalemia
0290-0000-17-199-H01-P
The panel for this activity will highlight pharmacoeconomic outcomes data and formulary decision-making strategies that can reduce the burden of hyperkalemia.
1.50